Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • strides

    Tag: strides

    You Searched For "strides"
    Strides get USFDA nod for Tetracycline Hydrochloride Capsules

    Strides get USFDA nod for Tetracycline Hydrochloride Capsules

    Medical Dialogues Bureau4 March 2020 9:30 AM IST
    Tetracycline Hydrochloride Capsule is an antibiotic used to treat many different bacterial infections of the skin, intestines, respiratory tract,...
    Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA

    Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA

    Medical Dialogues Bureau4 Nov 2019 4:31 PM IST
    New Delhi: Drug firm, Strides Pharma recently announced that the USFDA issued a statement1 on November 1, 2019, providing an update with the latest...
    Strides Pharma re-enters injectable biz by infusing Rs 280 crore for controlling stake in Stelis Biopharma

    Strides Pharma re-enters injectable biz by infusing Rs 280 crore for controlling stake in Stelis Biopharma

    Farhat Nasim21 Sept 2019 12:04 PM IST
    Bengaluru-based Strides has already invested USD 35 million (about Rs 245 crore) for a 43 per cent ownership in Stelis.New Delhi: Strides Pharma...
    Strides to exit investment in Arrow Pharma for over Rs 2000 crore

    Strides to exit investment in Arrow Pharma for over Rs 2000 crore

    Medical Dialogues Bureau30 Jan 2019 9:30 AM IST
    "Strides will receive AUD 300 million as upfront payment at the closure of the transaction, while the balance AUD 94 million to be deferred through a...
    Eris Life Sciences to acquire Strides India branded formulation business for Rs 500 crore: Report

    Eris Life Sciences to acquire Strides India branded formulation business for Rs 500 crore: Report

    Ruby Khatun Khatun18 Nov 2017 4:31 PM IST
    MUMBAI: Eris Life Sciences is going to acquire Stride Shasun India branded formulations business as the company has agreed to sell it for Rs 500 crore...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok